MSFP
BNTX icon

Mark Sheptoff Financial Planning’s BioNTech BNTX Stock Holding History

Mark Sheptoff Financial Planning’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-100
Closed -$17K – 388
2022
Q1 		$17K Hold
100
– – 0.01% 254
2021
Q4 		$26K Hold
100
– – 0.01% 229
2021
Q3 		$27K Sell
100
-100
-50% -$31.8K 0.01% 219
2021
Q2 		$45K Buy
+200
New +$37.7K 0.02% 198
2020
Q4 		– Sell
-500
Closed -$35K – 356
2020
Q3 		$35K Buy
+500
New +$35.9K 0.02% 161

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Mark Sheptoff Financial Planning's BNTX Position: Q2 2022 in Review

Mark Sheptoff Financial Planning sold out of BioNTech (BNTX) in Q2 2022, closing a stake of 100 shares — an estimated $17K sold.

Mark Sheptoff Financial Planning first reported a position in BNTX in Q3 2020 and held it in 5 quarters. The position peaked at $45K in Q2 2021. 293 funds tracked by Wall St. Rank hold BNTX as of Q2 2022.

  • Mark Sheptoff Financial Planning reported no remaining BioNTech position as of Q2 2022 after selling out during the quarter.
  • Mark Sheptoff Financial Planning sold 100 BioNTech shares in Q2 2022, an estimated $17K.
  • Mark Sheptoff Financial Planning first reported a position in BioNTech in Q3 2020 and held it in 5 quarters.
  • Mark Sheptoff Financial Planning's BioNTech position peaked at $45K in Q2 2021.
  • 293 funds tracked by Wall St. Rank held BioNTech as of Q2 2022.

Based on Mark Sheptoff Financial Planning's 13F filing for Q2 2022, filed 11 Aug 2022.